EKF Diagnostics Holdings Plc Net Assets

Latest as of June 2026: GBX71.58 Million GBX ≈ $8.71K USD

EKF Diagnostics Holdings Plc net assets. Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has net assets worth GBX71.58 Million GBX (≈ $8.71K USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX82.35 Million ≈ $10.02K USD) and total liabilities (GBX10.76 Million ≈ $1.31K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore EKF net assets growth trend to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	GBX71.58 Million
% of Total Assets	86.93%
Annual Growth Rate	27.31%
5-Year Change	-25.82%
10-Year Change	15.26%
Growth Volatility	260.65

Net Assets of EKF Diagnostics Holdings Plc (2001–2025)

Net assets of EKF Diagnostics Holdings Plc from 2001 to 2025. This chart illustrates how EKF Diagnostics Holdings Plc's net assets have evolved over time, based on quarterly financial data. See how leveraged is EKF Diagnostics Holdings Plc's balance sheet to measure how much of total assets are equity-financed.

Annual Net Assets for EKF Diagnostics Holdings Plc (2001–2025)

The table below shows the annual net assets of EKF Diagnostics Holdings Plc from 2001 to 2025. For live market cap and overall valuation, see EKF stock market capitalisation.

Year	Net Assets	Change
2025-12-31	GBX70.28 Million ≈ $8.55K	-4.01%
2024-12-31	GBX73.21 Million ≈ $8.91K	+7.32%
2023-12-31	GBX68.22 Million ≈ $8.30K	-8.46%
2022-12-31	GBX74.52 Million ≈ $9.07K	-21.34%
2021-12-31	GBX94.74 Million ≈ $11.53K	+21.15%
2020-12-31	GBX78.20 Million ≈ $9.51K	+9.87%
2019-12-31	GBX71.17 Million ≈ $8.66K	+11.37%
2018-12-31	GBX63.90 Million ≈ $7.78K	+5.63%
2017-12-31	GBX60.50 Million ≈ $7.36K	-0.78%
2016-12-31	GBX60.97 Million ≈ $7.42K	+30.41%
2015-12-31	GBX46.75 Million ≈ $5.69K	-46.49%
2014-12-31	GBX87.38 Million ≈ $10.63K	+113.52%
2013-12-31	GBX40.92 Million ≈ $4.98K	+3.79%
2012-12-31	GBX39.43 Million ≈ $4.80K	+5.34%
2011-12-31	GBX37.43 Million ≈ $4.55K	+59.07%
2010-12-31	GBX23.53 Million ≈ $2.86K	+318.67%
2009-12-31	GBX5.62 Million ≈ $683.79	+10.85%
2008-12-31	GBX5.07 Million ≈ $616.87	+1.89%
2007-12-31	GBX4.98 Million ≈ $605.44	+15.75%
2006-12-31	GBX4.30 Million ≈ $523.06	+15.75%
2005-12-31	GBX3.71 Million ≈ $451.89	+19.23%
2004-12-31	GBX3.12 Million ≈ $379.01	+26.73%
2003-12-31	GBX2.46 Million ≈ $299.07	+181.18%
2003-06-30	GBX-3.03 Million ≈ $-368.42	-204.34%
2002-12-31	GBX2.90 Million ≈ $353.09	+1256.07%
2001-12-31	GBX214.00K ≈ $26.04	--

Equity Component Analysis

This analysis shows how different components contribute to EKF Diagnostics Holdings Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 30041.0% over the analyzed period, indicating profitable operations and earnings retention.

EKF Diagnostics Holdings Plc Net Assets Breakdown (December 2025)

EKF Diagnostics Holdings Plc net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Retained Earnings	GBX52.14 Million	75.52%
Common Stock	GBX4.34 Million	6.28%
Other Comprehensive Income	GBX5.12 Million	7.42%
Other Components	GBX7.44 Million	10.78%
Total Equity	GBX69.05 Million	100.00%

EKF Diagnostics Holdings Plc Competitors by Market Cap

The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their market capitalization.

Company	Market Cap
SIG plc LSE:SHI	$1.27 Million
Bkm Industries Limited NSE:BKMINDST	$1.28 Million
Sileon AB ST:SILEON	$1.28 Million
Urban-Gro Inc NASDAQ:UGRO	$1.28 Million
Dixie Gold Inc V:DG	$1.27 Million
Virax Biolabs Group Limited Ordinary Shares NASDAQ:VRAX	$1.27 Million
Sono Group N.V. NASDAQ:SSM	$1.27 Million
Atomic Minerals Corp V:ATOM	$1.26 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EKF Diagnostics Holdings Plc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 72,327,000 to 69,050,000, a change of -3,277,000 (-4.5%).
Net income of 2,122,000 contributed positively to equity growth.
Share repurchases of 4,991,000 reduced equity.
Other comprehensive income decreased equity by 280,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	GBX2.12 Million	+3.07%
Share Repurchases	GBX4.99 Million	-7.23%
Other Comprehensive Income	GBX-280.00K	-0.41%
Other Changes	GBX-128.00K	-0.19%
Total Change	GBX-	-4.53%

Book Value vs Market Value Analysis

This analysis compares EKF Diagnostics Holdings Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 158.47x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 16760.75x to 158.47x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2001-12-31	GBX0.00	GBX24.40	x
2002-12-31	GBX0.03	GBX24.40	x
2003-12-31	GBX0.09	GBX24.40	x
2004-12-31	GBX0.09	GBX24.40	x
2005-12-31	GBX0.11	GBX24.40	x
2006-12-31	GBX0.13	GBX24.40	x
2007-12-31	GBX0.15	GBX24.40	x
2008-12-31	GBX0.15	GBX24.40	x
2009-12-31	GBX0.16	GBX24.40	x
2010-12-31	GBX0.24	GBX24.40	x
2011-12-31	GBX0.17	GBX24.40	x
2012-12-31	GBX0.14	GBX24.40	x
2013-12-31	GBX0.14	GBX24.40	x
2014-12-31	GBX0.22	GBX24.40	x
2015-12-31	GBX0.11	GBX24.40	x
2016-12-31	GBX0.13	GBX24.40	x
2017-12-31	GBX0.13	GBX24.40	x
2018-12-31	GBX0.14	GBX24.40	x
2019-12-31	GBX0.15	GBX24.40	x
2020-12-31	GBX0.17	GBX24.40	x
2021-12-31	GBX0.20	GBX24.40	x
2022-12-31	GBX0.16	GBX24.40	x
2023-12-31	GBX0.15	GBX24.40	x
2024-12-31	GBX0.16	GBX24.40	x
2025-12-31	GBX0.15	GBX24.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently EKF Diagnostics Holdings Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 3.07%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 4.12%
• Asset Turnover: 0.64x
• Equity Multiplier: 1.18x
Recent ROE (3.07%) is above the historical average (2.79%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	137.38%	26.82%	0.20x	25.46x	GBX272.60K
2002	4.93%	8.85%	0.25x	2.22x	GBX-147.20K
2003	-19.32%	-37.25%	0.20x	2.57x	GBX-720.80K
2004	-18.91%	-26.35%	0.34x	2.14x	GBX-900.50K
2005	20.81%	23.70%	0.67x	1.30x	GBX401.60K
2006	13.86%	19.37%	0.60x	1.20x	GBX166.10K
2007	9.34%	136.36%	0.06x	1.12x	GBX-32.60K
2008	-25.78%	-281.08%	0.08x	1.13x	GBX-1.81 Million
2009	-3.61%	-79.30%	0.04x	1.14x	GBX-765.00K
2010	-14.79%	-52.98%	0.18x	1.55x	GBX-5.76 Million
2011	-7.79%	-13.32%	0.37x	1.59x	GBX-6.59 Million
2012	4.70%	7.02%	0.47x	1.43x	GBX-2.06 Million
2013	-2.79%	-3.54%	0.52x	1.50x	GBX-5.17 Million
2014	-6.54%	-14.20%	0.30x	1.56x	GBX-14.39 Million
2015	-79.85%	-123.56%	0.42x	1.55x	GBX-41.77 Million
2016	-0.03%	-0.05%	0.47x	1.36x	GBX-6.06 Million
2017	4.53%	6.53%	0.54x	1.29x	GBX-3.28 Million
2018	15.91%	23.76%	0.52x	1.28x	GBX3.76 Million
2019	5.21%	8.19%	0.52x	1.23x	GBX-3.38 Million
2020	14.31%	17.03%	0.64x	1.30x	GBX3.35 Million
2021	16.84%	19.37%	0.71x	1.22x	GBX6.44 Million
2022	-13.77%	-15.16%	0.75x	1.22x	GBX-17.44 Million
2023	3.50%	4.47%	0.65x	1.20x	GBX-4.36 Million
2024	8.63%	12.44%	0.61x	1.13x	GBX-990.70K
2025	3.07%	4.12%	0.64x	1.18x	GBX-4.78 Million

Industry Comparison

This section compares EKF Diagnostics Holdings Plc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $47,585,559
Average return on equity (ROE) among peers: -18.76%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
EKF Diagnostics Holdings Plc (EKF)	GBX71.58 Million	137.38%	0.15x	$1.27 Million
AOTI Inc (AOTI)	$-5.91 Million	0.00%	0.00x	$1.74 Million
Creo Medical Group PLC (CREO)	$113.00K	0.00%	0.51x	$628.03K
Inspiration Healthcare Group PLC (IHC)	$28.97 Million	-20.83%	0.69x	$190.92K
NIOX Group PLC (NIOX)	$66.80 Million	5.39%	0.29x	$3.28 Million
Polarean Imaging Plc (POLX)	$7.79 Million	-72.42%	0.26x	$11.75K
Rua Life Sciences PLC (RUA)	$5.41 Million	-35.53%	0.12x	$192.55K
Smith & Nephew PLC (SN)	$273.58 Million	25.01%	1.35x	$118.24 Million
Surgical Innovations Group plc (SUN)	$3.93 Million	-51.73%	0.98x	$36.89K

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices

Market Cap

$1.27 Million

GBX10.44 Billion GBX

Market Cap Rank

#30481 Global

#765 in UK

Share Price

GBX24.40

Change (1 day)

-3.56%

52-Week Range

GBX21.80 - GBX28.40

All Time High

GBX78.21